Clinical Trial Update: Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Sorafenib for Inoperable Stage III Non-Small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluated cisplatin/etoposide with radiotherapy followed by sorafenib consolidation in inoperable stage III non-small cell lung cancer; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Etoposide (Etoposide)
• Sorafenib (Sorafenib)

Snippet

Sponsor: Nasser Hanna, M.D. | Conditions: Non-Small Cell Lung Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2016-07-25